Glycaemic markers

DIAGNOSTIC_TEST2 trials

Sponsors

Rigshospitalet, Denmark

Conditions

Continuous Glucose MonitoringDiabetic Nephropathy Type 2FructosamineGlycated AlbuminHbA1cPeritoneal DiseasesType2 Diabetes

Unknown Phase

Glycaemic Markers in Persons With Type 2 Diabetes on Haemodialysis

CompletedNCT03909269

Rigshospitalet, DenmarkDiabetic Nephropathy Type 2, Type2 Diabetes

Start: 2018-04-01End: 2020-04-01Updated: 2020-06-30

Glycaemic Markers in Persons With Type 2 Diabetes on Peritoneal Dialysis

CompletedNCT04125160

Rigshospitalet, DenmarkContinuous Glucose Monitoring, Fructosamine, Glycated Albumin +2

Start: 2019-11-12End: 2020-09-03Updated: 2020-09-29

Related Papers

Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomised, placebo-controlled clinical trial

BMJ Open2023-02-011 citations